You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epstein Barr virus infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis
  • Chronic Active Epstein-Barr Virus Infection
  • No intervention
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
May 2, 2023

Epstein Barr Virus Infection in Radiologically Isolated Syndrome

Recruiting
  • Multiple Sclerosis
  • +2 more
  • NO INTERVENTION
  • Nice, France
    Nice University Hospital
Apr 3, 2023

Genetic Studies of Chronic Active Epstein-Barr Disease

Recruiting
  • Chronic Active Epstein-Barr Virus
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Epstein-Barr Virus Infection moniToring in renAl Transplant

    Recruiting
    • EBV Infection
    • +3 more
    • EBV DNA in whole blood and plasma
    • Aarhus, Central Region Denmark, Denmark
    • +2 more
    Dec 12, 2022

    Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

    Recruiting
    • Secondary Hemophagocytic Lymphohistiocytosis
    • Chronic Active Epstein-Barr Virus Infection
    • Rituximab Monotherapy
    • Beijing, China
      Zhao Wang
    May 18, 2022

    CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

    Not yet recruiting
    • CMV Infection
    • +2 more
    • Virus specific T cells
    • (no location specified)
    Oct 4, 2023

    Immunodeficiency for Severe Epstein-Barr Virus Infection

    Recruiting
    • Epstein-Barr Virus Infections
    • Immunodeficiency
      • Shanghai, Shanghai, China
        Children's Hospital of Fudan University
      Mar 21, 2022

      Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and

      Not yet recruiting
      • Epstein-Barr Virus Infection
      • +2 more
      • Matrix-M1 Adjuvant
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      EBV Infection Trial in Belgium (2LEBV® / 2LXFS®, Placebo)

      Recruiting
      • EBV Infection
      • 2LEBV® / 2LXFS®
      • Placebo
      • Aartselaar, Belgium
      • +12 more
      Dec 22, 2022

      EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis Trial run by the NIAID (EBV gp350-Ferritin Vaccine, Matrix-M1)

      Recruiting
      • EBV
      • +2 more
      • EBV gp350-Ferritin Vaccine
      • Matrix-M1
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 11, 2022

      Fatigue Syndrome, Chronic, Epstein-Barr Virus Infection Trial in Lørenskog (Mental training)

      Completed
      • Fatigue Syndrome, Chronic
      • Epstein-Barr Virus Infection
      • Mental training
      • Lørenskog, Akershus, Norway
        Dept. of Pediatrics, Akershus University Hospital
      Feb 14, 2022

      Study on Infectious Mononucleosis in Munich

      Completed
      • Infectious Mononucleosis
      • Epstein-Barr Virus Infections
        • Munich, Bavaria, Germany
          MRI Chonic Fatigue Center for Young People (MCFC), Children's Ho
        Aug 16, 2023

        ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München

        Recruiting
        • ME/CFS
        • +3 more
          • München, Germany
            München Klinik Schwabing
          Mar 20, 2023

          Epstein-Barr Virus Infection Trial in United States (mRNA-1189, Placebo)

          Recruiting
          • Epstein-Barr Virus Infection
          • mRNA-1189
          • Placebo
          • Hollywood, Florida
          • +15 more
          Jul 14, 2022

          Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

          Not yet recruiting
          • Acute Lymphoblastic Leukemia in Remission
          • +10 more
          • CliniMACS
          • Houston, Texas
          • +1 more
          Dec 8, 2022

          Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

          Active, not recruiting
          • Acute Lymphoblastic Leukemia
          • +9 more
          • iCaspase9-transduced T cells
          • AP1903
          • Houston, Texas
          • +1 more
          Jul 22, 2022

          Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

          Recruiting
          • Epstein-Barr Virus Infections
          • Primary Immune Deficiency Disorder
          • cytotoxic t-lymphocytes
          • Los Angeles, California
          • +7 more
          Sep 27, 2022

          EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

          Recruiting
          • EBV Infection After Allogenic HSCT
          • EBV-TCR-T cells
          • Beijing, Beijing, China
            Chinese PLA General Hospital
          Nov 3, 2023

          Epstein-Barr Virus Infection Trial in United States (mRNA-1195.1, mRNA-1195.2, mRNA-1189)

          Recruiting
          • Epstein-Barr Virus Infection
          • mRNA-1195.1
          • +3 more
          • Anniston, Alabama
          • +29 more
          Apr 14, 2023

          EBV-positive Gastric Cancer and Multiple Genes Associated With

          Completed
          • Gastric Cancer
          • +2 more
          • Gastrectomy
          • Suwon, Gyeong-Gi-Do, Korea, Republic of
            Jiwon Seo
          Oct 28, 2022

          EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

          Recruiting
          • EBV-associated Hemophagocytic Lymphohistiocytosis
          • EBV Infection
          • EBV-TCR-T cells
          • Beijing, Beijing, China
            Chinese PLA General Hospital
          Nov 12, 2023

          Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T

          Not yet recruiting
          • Epstein-Barr Virus Infections
          • +3 more
          • Rapidly generated virus specific T (R-MVST) cells
          • New York, New York
            Columbia University Irving Medical Center
          Feb 18, 2022

          Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

          Recruiting
          • Epstein-Barr Virus Infections
          • +2 more
          • Group A
          • Group B
          • Montreal, Quebec, Canada
            Hôpital Maisonneuve-Rosemont
          Apr 5, 2022

          Epstein-Barr Virus Infections Trial in Strasbourg (Rituximab, control group)

          Recruiting
          • Epstein-Barr Virus Infections
          • Strasbourg, France
            Les Hôpitaux Universitaires de Strasbourg
          Dec 7, 2021

          EBV Infection Trial in Beijing (PD1 antibody, lenalidomide)

          Recruiting
          • EBV Infection
          • Beijing, Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Jan 4, 2022